Chiome Bioscience is an outsourced company of RIKEN. The AdLib technology allows the rapid production of antibodies in vitro using a gene conversion mechanism in cells derived from chickens. The system enables the creation of otherwise difficult-to-make antibodies with unlimited diversity Fujirebio will use the technology to stimulate antibody production against haptens.

RIKEN news release, July 8, 2013